These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1490304)

  • 21. Antioxidant effect of probucol on RO2*/O2(*-)-induced peroxidation of human low-density lipoproteins.
    Bonnefont-Rousselot D; Segaud C; Jore D; Delattre J; Gardès-Albert M
    Radiat Res; 1999 Mar; 151(3):343-53. PubMed ID: 10073673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probucol protects low-density lipoproteins from in vitro and in vivo oxidation.
    Bittolo-Bon G; Cazzolato G; Avogaro P
    Pharmacol Res; 1994; 29(4):337-44. PubMed ID: 7971685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations.
    Schwenke DC; Behr SR
    Circ Res; 1998 Aug; 83(4):366-77. PubMed ID: 9721693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases.
    Santanam N; Parthasarathy S
    J Clin Invest; 1995 Jun; 95(6):2594-600. PubMed ID: 7769102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin E supplementation increases the resistance of both LDL and HDL to oxidation and increases cholesteryl ester transfer activity.
    Arrol S; Mackness MI; Durrington PN
    Atherosclerosis; 2000 May; 150(1):129-34. PubMed ID: 10781643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of antioxidants on the oxidative susceptibility of low-density lipoprotein.
    Hirano R; Kondo K; Iwamoto T; Igarashi O; Itakura H
    J Nutr Sci Vitaminol (Tokyo); 1997 Aug; 43(4):435-44. PubMed ID: 9328862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probucol prevents oxidative injury to endothelial cells.
    Kuzuya M; Naito M; Funaki C; Hayashi T; Asai K; Kuzuya F
    J Lipid Res; 1991 Feb; 32(2):197-204. PubMed ID: 2066656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro.
    Regnström J; Walldius G; Carlson LA; Nilsson J
    Atherosclerosis; 1990 May; 82(1-2):43-51. PubMed ID: 2360919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probucol reduces plasma lipid peroxides in man.
    Paterson JR; Rumley AG; Oldroyd KG; Tait GW; Smellie WS; Packard CJ; Shepherd J; Lorimer AR
    Atherosclerosis; 1992 Nov; 97(1):63-6. PubMed ID: 1445494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon.
    Denton CP; Bunce TD; Dorado MB; Roberts Z; Wilson H; Howell K; Bruckdorfer KR; Black CM
    Rheumatology (Oxford); 1999 Apr; 38(4):309-15. PubMed ID: 10378706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia.
    Dachet C; Jacotot B; Buxtorf JC
    Atherosclerosis; 1985 Dec; 58(1-3):261-8. PubMed ID: 4091882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of probucol in reducing plasma low-density lipoprotein cholesterol oxidation in hypercholesterolemia.
    Masana L; Bargalló MT; Plana N; LaVille A; Casals I; Solà R
    Am J Cardiol; 1991 Oct; 68(9):863-7. PubMed ID: 1927944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ameliorative effect of dietary probucol on polychlorinated biphenyls-induced hypercholesterolemia and lipid peroxidation in the rat.
    Yamamoto K; Fukuda N; Shiroi S; Shiotsuki Y; Nagata Y; Tani T; Sakai T
    Life Sci; 1994; 54(14):1019-26. PubMed ID: 8139383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The resistance of low density lipoprotein to oxidation promoted by copper and its use as an index of antioxidant therapy.
    O'Leary VJ; Tilling L; Fleetwood G; Stone D; Darley-Usmar V
    Atherosclerosis; 1996 Jan; 119(2):169-79. PubMed ID: 8808494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose colestipol plus probucol for hypercholesterolemia.
    Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H
    Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary probucol preserves endothelium-dependent relaxation of arteriovenous fistula in hypercholesterolemic rabbits.
    Wang YC; Tsai FC; Chu Y; Yan CY; Deng YH; Lin PJ
    Chang Gung Med J; 2006; 29(6):561-7. PubMed ID: 17302219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans.
    McDowell IF; Brennan GM; McEneny J; Young IS; Nicholls DP; McVeigh GE; Bruce I; Trimble ER; Johnston GD
    Eur J Clin Invest; 1994 Nov; 24(11):759-65. PubMed ID: 7890014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits.
    Shaish A; Daugherty A; O'Sullivan F; Schonfeld G; Heinecke JW
    J Clin Invest; 1995 Oct; 96(4):2075-82. PubMed ID: 7560102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic.
    Fuhrman B; Volkova N; Rosenblat M; Aviram M
    Antioxid Redox Signal; 2000; 2(3):491-506. PubMed ID: 11229363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of long-term treatment with probucol on serum lipoproteins in cases of familial hypercholesterolemia in the elderly.
    Morisaki N; Mori S; Kobayashi J; Ishikawa Y; Shinomiya M; Shirai K; Saito Y; Yoshida S
    J Am Geriatr Soc; 1990 Jan; 38(1):15-8. PubMed ID: 2295765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.